4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-002175
SVP, Chief Financial Officer gave up 4,508 shares (to pay taxes)
- SVP, Chief Financial Officer acquired 11,392 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Stelzer Laurie · SVP, Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-22 | Exercise or conversion : show line 1 in the form | +11,392 | 120,675 | D | ||
| 2020-02-22 | Shares withheld for taxes : show line 2 in the form | −4,508 | $21.83 | $98,410 | 116,167 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-02-22 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −11,392 | $0.00 | 11,392 | 11,392 | D |
Loading xslF345X03/edgar.xml…